Gene-Targeting Therapy Delivers Stunning 91 Percent Seizure Reduction in Children With Rare Epilepsy

A gene-targeting therapy has delivered a stunning 91 percent reduction in seizures in children with a rare and devastating form of epilepsy, offering hope to families who have watched their children suffer dozens of seizures daily with no effective treatment options. The therapy targets the specific genetic mutation responsible for the condition, representing the growing power of precision medicine to treat diseases at their molecular root rather than merely managing symptoms. For the children in the trial, many of whom had been resistant to every conventional treatment, the results represent a transformation from constant neurological crisis to something approaching normalcy.